Benzinga - Thu, 25 Feb 2021 05:57:48 -0400
Benzinga - Wed, 24 Feb 2021 13:35:07 -0400
Benzinga - Thu, 11 Feb 2021 10:22:08 -0400
Benzinga - Thu, 11 Feb 2021 07:41:10 -0400
Benzinga - Thu, 11 Feb 2021 05:04:36 -0400
Benzinga - Wed, 10 Feb 2021 14:12:43 -0400
Benzinga - Wed, 10 Feb 2021 14:06:17 -0400
Benzinga - Wed, 10 Feb 2021 12:47:07 -0400
load more
Sector: Health Care.Industry: Biotechnology
Cancer Genetics Inc through its vivoPharm subsidiary offers proprietary preclinical test systems supporting clinical diagnostic offerings at early stages, valued by the pharmaceutical industry, biotechnology companies, and academic research centers. The company is focused on precision and translational medicine to drive drug discovery and novel therapies. Its subsidiary, vivoPharm specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug filings. VivoPharm operates in The Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) accredited and GLP compliant audited facilities.

Earnings

see more
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-06-01
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CGIXCancer Genetics7.24%59.5M

Cancer Genetics Company Questions & Answers

Q

How do I buy Cancer Genetics (CGIX) stock?

A

You can purchase shares of Cancer Genetics (NASDAQ: CGIX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cancer Genetics's (CGIX) main competitors?

A

Other companies in Cancer Genetics’s space includes: Brickell Biotech (NASDAQ:BBI), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Edesa Biotech (NASDAQ:EDSA).

Q

What is the target price for Cancer Genetics?

A

The latest price target for Cancer Genetics (NASDAQ: CGIX) was reported by Maxim Group on 2018-04-03. The analyst firm set a price target for 0.00 expecting CGIX to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

How much is Cancer Genetics (CGIX) stock ?

A

The stock price for Cancer Genetics (NASDAQ: CGIX) is $5.63 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Cancer Genetics (CGIX) dividend?

A

There are no upcoming dividends for Cancer Genetics.

Q

When is Cancer Genetics (NASDAQ:CGIX) reporting earnings?

A
Cancer Genetics’s Q4 earnings are confirmed after-market from now on June 1, 2021.
Q

When is the upcoming split for CGIX?

A

There is no upcoming split for Cancer Genetics.